Impact of Decitabine Conditioning on Allo‐HSCT Outcomes in AML and Intermediate‐to‐High‐Risk MDS Patients in Remission

ABSTRACT:

SUBMITTER: Yu S 

PROVIDER: S-EPMC12284727 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature